Triochem Products

17.40
+17.40
(0.00%)
Market Cap
0.40 Cr
EPS
-41.36
PE Ratio
-
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
0.00
52 Week Low
0.00
PB Ratio
0.04
Debt to Equity
0.00
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,716.80
#1 4,11,917.83
34.33
#1 49,887.20
12.06
#1 9,648
13.77
47.60
5,672.00
1,50,573.78
71.83
8,184.00
0.89
1,600
#1 64.53
47.92
1,471.70
1,18,856.69
23.68
26,520.70
14.17
4,155
47.38
50.89
3,201.90
1,08,366.85
56.84
10,785.70
11.59
1,656
13.54
45.29
2,403.10
99,146.75
47.52
10,615.60
19.57
1,942
-16.38
48.68
1,143.10
95,386.59
#1 17.23
28,905.40
12.36
5,578
1.69
40.66
2,008.30
91,687.12
31.34
20,141.50
#1 19.94
1,936
38.82
46.62
876.45
88,191.38
19.27
19,831.50
13.82
3,831
29.92
44.56
1,120.10
65,055.59
17.83
29,559.20
17.55
3,169
-10.04
41.61
30,110.00
63,981.65
47.10
6,097.20
10.80
1,201
16.01
48.36
Growth Rate
Revenue Growth
233.33 %
Net Income Growth
11.11 %
Cash Flow Change
-265.05 %
ROE
-9.17 %
ROCE
-9.81 %
EBITDA Margin (Avg.)
-97.88 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
31
23
18
35
12
21
14
9
0
1
2
Expenses
30
22
17
31
11
16
14
8
1
1
2
EBITDA
1
1
1
4
2
5
-0
2
-1
-0
0
Operating Profit %
4 %
4 %
5 %
11 %
13 %
22 %
-3 %
15 %
0 %
0 %
0 %
Depreciation
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
1
0
0
0
0
0
0
Profit Before Tax
1
1
1
4
1
5
-1
2
-1
-1
0
Tax
0
0
0
1
0
1
-0
0
-0
-0
-0
Net Profit
0
0
1
3
1
3
-0
1
-1
-1
0
EPS in ₹
16.98
13.94
23.51
104.29
30.33
138.89
-18.24
53.99
-36.12
-41.36
12.20

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
9
7
10
12
15
17
12
13
12
15
Fixed Assets
2
2
2
1
1
1
1
1
1
1
Current Assets
6
1
8
10
14
15
11
12
1
3
Capital Work in Progress
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
9
11
Other Assets
6
5
9
10
14
16
11
13
2
3
Total Liabilities
9
7
10
12
15
17
12
13
12
15
Current Liabilities
4
2
5
4
6
4
0
0
0
0
Non Current Liabilities
0
0
0
0
0
0
0
0
0
0
Total Equity
5
5
6
8
9
12
12
13
12
15
Reserve & Surplus
4
5
5
8
9
12
12
13
11
14
Share Capital
0
0
0
0
0
0
0
0
0
0

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
1
-1
0
1
-1
0
8
4
-11
-0
Investing Activities
-0
-4
4
0
0
0
0
0
-10
3
Operating Activities
2
7
-7
2
-4
4
10
4
-1
-4
Financing Activities
-2
-4
3
-1
3
-4
-3
0
0
0

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
68.65 %
68.65 %
68.65 %
68.65 %
68.65 %
68.65 %
68.65 %
68.65 %
68.65 %
68.65 %
68.65 %
68.65 %
68.65 %
68.65 %
68.65 %
68.65 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
15.53 %
15.53 %
15.53 %
15.53 %
15.53 %
15.53 %
15.53 %
15.53 %
15.53 %
15.53 %
15.53 %
15.53 %
15.53 %
15.53 %
15.53 %
15.53 %
Others
15.82 %
15.82 %
15.82 %
15.82 %
15.82 %
15.82 %
15.82 %
15.82 %
15.82 %
15.82 %
15.82 %
15.82 %
15.82 %
15.82 %
15.82 %
15.82 %
No of Share Holders
55
55
55
55
55
55
55
55
55
55
55
55
55
55
55
55

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Announcements

Disclosures By Listed Entities Of Defaults On Payment Of Interest/ Repayment Of Principal Amount For Loans Including Revolving Facilities Like Cash Credit From Banks / Financial InstitutionsApr 02, 2025
Disclosures By Listed Entities Of Defaults On Payment Of Interest/ Repayment Of Principal Amount For Loans Including Revolving Facilities Like Cash Credit From Banks / Financial InstitutionsApr 02, 2025
Quarterly Disclosures By Listed Entities Of Defaults On Payment Of Interest/ Repayment Of Principal Amount On Loans From Banks / Financial Institutions And Unlisted Debt SecuritiesApr 02, 2025
Quarterly Disclosures By Listed Entities Of Defaults On Payment Of Interest/ Repayment Of Principal Amount On Loans From Banks / Financial Institutions And Unlisted Debt SecuritiesApr 02, 2025
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2Apr 02, 2025
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2Apr 02, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 02, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 02, 2025
Compliance-57 (5) : intimation after the end of quarterApr 02, 2025
Compliance-57 (5) : intimation after the end of quarterApr 02, 2025
Compliance-57 (4) : Prior intimation to the beginning of the quarterMar 29, 2025
Closure of Trading WindowMar 29, 2025
Announcement under Regulation 30 (LODR)-RetirementMar 28, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMar 28, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateMar 28, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday 28Th March 2025Mar 28, 2025
Board Meeting Outcome for Outcome Of The Independent DirectorS Meeting - Pursuant To Regulation 25(3) Of The SEBI (Listing Obligations And Disclosures Requirements) Regulation 2015Mar 21, 2025
Board Meeting Intimation for Meeting Of Board Of Director Of Triochem Products Limited Will Be Held On Friday 28Th March 2025 At 03.00 P.M. At The Registered Office Of Company Inter-Alia To Transact The Following Business:-Mar 20, 2025
Board Meeting Intimation for Separate Board Meeting Of Independent DirectorS Under Regulation 25(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 13, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 13, 2025
Integrated Filing (Financial)Feb 12, 2025
Submission Of Statement Of Deviation Or Variation In Public Issue Rights Issue Preferential Issue Etc. Under Regulation 32(1) Of The SEBI (Listing Obligation & Disclosures Requirement) Regulation 2015Feb 12, 2025
Submission Of Unaudited Standalone Financial Results For The Quarter And Nine Months Ended 31St December 2024Feb 12, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On Wednesday 12Th February 2025Feb 12, 2025
Announcement under Regulation 30 (LODR)-Meeting UpdatesFeb 10, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 05, 2025
Board Meeting Intimation for Intimation Of Board Meeting For The Quarter And Nine Months Ended 31St December 2024 Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) ReguFeb 04, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 14, 2025
Announcement under Regulation 30 (LODR)-Change in RTAJan 14, 2025
Disclosures By Listed Entities Of Defaults On Payment Of Interest/ Repayment Of Principal Amount For Loans Including Revolving Facilities Like Cash Credit From Banks / Financial IJan 14, 2025
Quarterly Disclosures By Listed Entities Of Defaults On Payment Of Interest/ Repayment Of Principal Amount On Loans From Banks / Financial Institutions And Unlisted Debt SecuritiesJan 14, 2025
Compliance-57 (5) : intimation after the end of quarterJan 14, 2025
Compliance-57 (4) : Prior intimation to the beginning of the quarterDec 30, 2024
Closure of Trading WindowDec 30, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 14, 2024
Statement Of Deviation Or Variation In Public Issue, Rights Issue, Preferential Issue, Etc. Under Regulation 32(1) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Quarter Ended 30Th September 2024Nov 13, 2024
Submission Of Unaudited Standalone Financial Results For The Quarter And Half Year Ended 30Th September 2024Nov 13, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Held On Wednesday 13Th November 2024Nov 13, 2024
Outcome Of The Board Meeting Held On Wednesday 13Th November 2024Nov 13, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 07, 2024
Board Meeting Intimation for Intimation Of Board Meeting For The Quarter Ended 30Th September 2024 Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015Nov 06, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 07, 2024
Disclosures By Listed Entities Of Defaults On Payment Of Interest/ Repayment Of Principal Amount For Loans Including Revolving Facilities Like Cash Credit From Banks / Financial InstitutionsOct 07, 2024
Quarterly Disclosures By Listed Entities Of Defaults On Payment Of Interest/ Repayment Of Principal Amount On Loans From Banks / Financial Institutions And Unlisted Debt SecuritiesOct 07, 2024
Compliance-57 (5) : intimation after the end of quarterOct 07, 2024
Closure of Trading WindowSep 27, 2024
Compliance-57 (4) : Prior intimation to the beginning of the quarterSep 27, 2024
Announcement under Regulation 30 (LODR)-Meeting UpdatesAug 22, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMAug 22, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportAug 22, 2024

Technical Indicators

RSI(14)
Overbought
96.01
ATR(14)
Less Volatile
0.35
STOCH(9,6)
Overbought
100.00
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
0.00
ADX(14)
Weak Trend
0.00
UO(9)
Bullish
0.00
ROC(12)
Uptrend And Accelerating
25.45
WillR(14)
Overbought
0.00